Economic burden of avoidable blindness due to diabetic macular edema in Ecuador
The cost to society of providing timely treatment for diabetic retinopathy and diabetic macular edema is significantly less than the cost of supporting a person that has become blind due to lack of treatment. Thus, it would be prudent to invest in public policies that prevent and treat diabetes-related visual impairment.
Authors
- Paula Luque
- Juan Antonio Terán
- Ruth Lucio
Institutions
- Instituto Nacional de Biodiversidad (EC)
- Center for the Study of State and Society (AR)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2025-07-14
- DOI
- https://doi.org/10.3389/fpubh.2025.1476932
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- Roche